iRhythm Technologies, Inc. (IRTC)
Market Cap | 3.66B |
Revenue (ttm) | 410.92M |
Net Income (ttm) | -116.16M |
Shares Out | 30.22M |
EPS (ttm) | -3.88 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 261,659 |
Open | 118.64 |
Previous Close | 119.23 |
Day's Range | 117.57 - 121.55 |
52-Week Range | 85.74 - 169.54 |
Beta | 1.41 |
Analysts | Buy |
Price Target | 144.97 (+19.6%) |
Earnings Date | May 4, 2023 |
About IRTC
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and E... [Read more]
Financial Performance
In 2022, IRTC's revenue was $410.92 million, an increase of 27.29% compared to the previous year's $322.83 million. Losses were -$116.16 million, 14.6% more than in 2021.
Financial StatementsAnalyst Forecast
According to 17 analysts, the average rating for IRTC stock is "Buy." The 12-month stock price forecast is $144.97, which is an increase of 19.60% from the latest price.
News

iRhythm Technologies (IRTC) Soars 3.9%: Is Further Upside Left in the Stock?
iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength...

10 Companies That Had Tons of Money in SVB When It Collapsed
Since SVB Financial's (NASDAQ: SIVB) principal subsidiary, Silicon Valley Bank, collapsed last week, Wall Street has been in turmoil. With SVB seized by government regulators and New York's Signature...

4 Stocks With Huge Cash Holdings at Silicon Valley Bank
We're witnessing the second-largest bank failure in United States history as regulators shut down Silicon Valley Bank (NASDAQ: SIVB). Nobody has any idea what the implications are.

Large Real-World Evidence Analysis Demonstrates that Zio® XT Is Associated With the Highest Diagnostic Yield, Lowest Retesting Rates, and Fastest Time to Clinical Diagnosis Compared to Other Ambulatory ECG Monitors
Additional studies presented at ACC.23/WCC reinforce the clinical value of the Zio suite of products and services Additional studies presented at ACC.23/WCC reinforce the clinical value of the Zio sui...

Four New Studies Featuring Zio® by iRhythm to be Presented at ACC.23/WCC
iRhythm continues to expand its strong body of clinical and scientific evidence with new research presented by leading clinical investigators at the conference

iRhythm Technologies Announces Fourth Quarter and Full Year 2022 Financial Results
SAN FRANCISCO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preven...

iRhythm Technologies to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
SAN FRANCISCO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict...

iRhythm Technologies Shares Preliminary Fourth Quarter 2022 Highlights and Business Update at the 41st Annual J.P. Morgan Healthcare Conference
SAN FRANCISCO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent...

iRhythm® Technologies to Present at the 41st Annual J.P. Morgan Healthcare Conference
SAN FRANCISCO, Dec. 27, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent...

Results of Four Studies Demonstrating Clinical, Economic Value of iRhythm's Product Portfolio Presented at American Heart Association '22
Clinical studies presented at the American Heart Association 2022 Scientific Sessions event demonstrate compelling diagnostic and health economic value of the Zio® suite of products across a range of ...

New Research Confirms that Zio® by iRhythm Provides High Value From a Health Economic Perspective
A new analysis of iRhythm's mSToPS trial, presented at the American Heart Association, reveals that Zio® XT provided high value from a health economic perspective A new analysis of iRhythm's mSToPS tr...

iRhythm® Technologies Comments on the Final Medicare Physician Fee Schedule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023
SAN FRANCISCO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict...

iRhythm® Technologies Comments on the Announcement of the Medicare Physician Fee Schedule Final Rule Released by the Centers for Medicare and Medicaid Services for Calendar Year 2023
SAN FRANCISCO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict...

IRhythm Technologies (IRTC) Reports Q3 Loss, Misses Revenue Estimates
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of 23.17% and 2.40%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock...

iRhythm Technologies Announces Third Quarter 2022 Financial Results
SAN FRANCISCO, Nov. 01, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predic...

7 Robotic Stocks to Buy for the Coming Robot Boom
The robotics industry has been growing at an incredible pace, and the computing power needed for these mechatronic devices is getting cheaper by the day. The increased computing power and data handlin...

7 Momentum Stocks to Buy Now for Extraordinary Gains
Before jumping directly into momentum stocks worth buying now, it's important to understand what momentum trading is. As the name implies, momentum trading relies on reacting to the current movement o...

iRhythm Technologies Details Growth Strategies at 2022 Analyst & Investor Day
SAN FRANCISCO, Sept. 21, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent and predic...

iRhythm Technologies to Host Analyst & Investor Day on September 21, 2022
SAN FRANCISCO, Aug. 31, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced ...

IRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of 15.96% and 2.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

iRhythm Technologies to Present at the Canaccord Genuity 42nd Annual Growth Conference
SAN FRANCISCO, July 28, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced th...

Analysts Estimate iRhythm Technologies (IRTC) to Report a Decline in Earnings: What to Look Out for
IRhythm Technologies (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

iRhythm Technologies Announces the Addition of Two Executive Leaders to Advance Strategic Growth and Operational Excellence
SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced th...

iRhythm Gains FDA Clearance for its Clinically Integrated ZEUS System
Developed in partnership with Verily, the Zio® Watch and the ZEUS System combine to create a clinical grade watch to detect and characterize AFib and integrate with clinician's workflow Developed in p...

iRhythm Technologies Announces Chief Commercial Officer Transition and Schedules Second Quarter Earnings Release and Conference Call for August 4, 2022
SAN FRANCISCO, July 18, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced th...